Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Pharmacy Department, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Future Oncol. 2021 Feb;17(4):435-442. doi: 10.2217/fon-2020-0544. Epub 2021 Jan 5.
Desmoid tumor (DT) is a rare, locally aggressive benign neoplasm with a high recurrence rate. The majority of sporadic DTs are associated with mutations in , but whether mutations are associated with the risk of DT recurrence remains unclear. The goal of this meta-analysis was to evaluate the association between mutation and recurrence in surgically treated DT patients. PubMed, Embase and Cochrane library were systematically searched. The outcome of interest was the risk of recurrence. The number of patients with mutation and the number of recurrences they developed were recorded and compared. The quality of these studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. Odds ratios and variances were calculated and pooled. A total of eight studies were identified including 637 patients. S45F-mutated DTs were more likely to recur compared with wild type, T41A and other mutated DTs. However, there were no statistically significant differences in the rate of recurrence between wild type and T41A mutation or other mutation. Among mutations, the mutation S45F is a high-risk factor for recurrence of DT and may be a predictive marker for the recurrence of sporadic DT.
硬纤维瘤(DT)是一种罕见的局部侵袭性良性肿瘤,复发率较高。大多数散发性 DT 与 基因突变有关,但 突变是否与 DT 复发的风险相关尚不清楚。本荟萃分析的目的是评估 突变与手术治疗 DT 患者复发之间的关系。系统检索了 PubMed、Embase 和 Cochrane 图书馆。感兴趣的结局是复发风险。记录并比较了携带 突变的患者人数和他们发生的复发次数。使用纽卡斯尔-渥太华质量评估量表评估这些研究的质量。计算并合并了比值比和方差。共确定了 8 项研究,包括 637 名患者。与野生型、T41A 和其他突变型 DT 相比,S45F 突变型 DT 更有可能复发。然而,野生型和 T41A 突变或其他突变之间的复发率没有统计学上的显著差异。在 突变中,突变 S45F 是 DT 复发的高危因素,可能是散发性 DT 复发的预测标志物。